Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-04-30T21:25:57.141Z Has data issue: false hasContentIssue false
  • English
  • Français

20 Is asymptomatic carotid artery stenosis really asymptomatic?

Published online by Cambridge University Press:  24 June 2014

M. Mijajlovic ,
N. Sternic ,
A. Jotic  and
N. Lalic
M. Mijajlovic
Affiliation:
Institute of Neurology, Institute of Endocrinology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia, E-mail: milijamijajlovic@yahoo.com
N. Sternic
Affiliation:
Institute of Neurology, Institute of Endocrinology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia, E-mail: milijamijajlovic@yahoo.com
A. Jotic
Affiliation:
Institute of Neurology, Institute of Endocrinology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia, E-mail: milijamijajlovic@yahoo.com
N. Lalic
Affiliation:
Institute of Neurology, Institute of Endocrinology, Clinical Center of Serbia, Dr Subotica 6, 11000 Belgrade, Serbia, E-mail: milijamijajlovic@yahoo.com
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Posters – Neurology
Information
Acta Neuropsychiatrica , Volume 21 , Issue S2: Special Issue: Abstracts of 49th Neuropsychiatric Pula Congress, 17-20 June 2009, Pula, Croatia , June 2009 , pp. 79
Copyright
Copyright © 2009 John Wiley & Sons A/S

Introduction/Objectives:

Asymptomatic carotid artery stenosis (ACAS) contributes stenosis of one or both internal carotid arteries, without cerebral ischemia related to it (transient ischemic attack, cerebral infarction, amaurosis fugax). Several studies showed that ACAS is not really asymptomatic and it is frequently associated with cognitive decline.

This study was aimed to analyze association between vascular risk factors, especially insulin resistance, and cognitive decline in 100 patients with ACAS and 50 age-, sex- and educational level healthy matched control subjects.

Participants, Materials/Methods:

Insulin resistance was tested by homeostasis assessment model (HOMA IR), plasma insulin levels by radioimmunoassay, levels of total-, LDL-, HDL- cholesterol, triglycerides and plasminogen activator inhibitor-1 were measured. Carotid plaques characteristics and intima-media thickness (IMT) were determined by ultrasound system (ALOKA Alpha 10, Japan). We used detailed neuropsychological testing to examine attention and concentration, memory, executive and visual constructional functions, motor performance, language and speech. Study was prospective and all patients were followed-up for 2 years.

Results:

In comparison with controls, ACAS patients had significantly lower results on all neuropsychological tests at the beginning (F [1.71] = 6.37; P < 0.001), and after 2 years of follow-up, with further cognitive decline from the baseline (F [1.71] = 71.12; P < 0.001).Insulin resistance was significantly associated with memory, language and visuospatial disturbances (CC = -0. 3891; P < 0.001) and carotid plaques characteristics with attention, executive and motor functions (CC = -0.4662: P < 0.001).

Conclusions:

ACAS is not asymptomatic, because it is associated with specific profile of cognitive impairment. Specific risk factors predict cognitive decline in certain neuropsychological domains, and this could have important therapeutical implications.